---
name: Altruist Biologics
slug: altruist-biologics
site: cdmo
website_domain: altruistbio.com
summary: Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors. Headquartered in Suzhou, China.
tagline: End-to-end biologics development and manufacturing from molecule to market
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CN
tier2_domain_verified: false
updated_at: 2026-08-07T00:04:03.344Z
services_count: 10
modalities_count: 3
indications_count: 0
locations_count: 2
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Altruist Biologics

End-to-end biologics development and manufacturing from molecule to market

Listed on cdmo.directory.

## Summary

Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors. Headquartered in Suzhou, China.

## At a glance

- HQ country: CN

## Services

- Cell-Line Development
- Process Development
- Formulation Development
- CMC Analytical Development
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Bioconjugation Services
- ADC (Antibody-Drug Conjugate) Manufacturing
- CMC Regulatory Submission Support
- Secondary Packaging & Labeling

## Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Biologics (Other)

## Locations

- Suzhou, Suzhou, China
- Hangzhou, Hangzhou, China

## Long description

## Overview

Altruist Biologics is a global contract development and manufacturing organization (CDMO) dedicated to delivering flexible, end-to-end biologics solutions from molecule to market. Backed by Innovent's well-established technical expertise, the company combines scientific expertise with accessible solutions to help partners advance life-saving medicines to patients around the globe.

## Capabilities & Services

### Development Services
- **Mammalian Cell Line Development:** Flexible cell culture services shaped around IND/BLA milestones
- **Process Development:** Comprehensive process optimization for biologics
- **Formulation Development:** Drug product formulation expertise
- **Analytical Method Development:** CMC-supporting analytical capabilities

### Manufacturing Services
- **GMP Drug Substance Manufacturing:** Clinical- and commercial-scale production
- **GMP Drug Product Manufacturing:** Integrated drug product services
- **Labeling & Packaging:** Secondary packaging and labeling solutions

### Bioconjugates
- **ADC and Bioconjugation Development:** All-in-one development and manufacturing for antibody-drug conjugates and other novel bioconjugates
- **GMP Drug Substance & Product Manufacturing:** Full-scale bioconjugate production

### Regulatory Support
- Comprehensive, seamlessly integrated CMC (Chemistry, Manufacturing, and Controls) services

## Modalities Served

Altruist serves a spectrum of modalities including monoclonal antibodies, bispecific and multispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates.

## Facilities

**Suzhou:** Located at the heart of a global biomanufacturing hub, the Suzhou facility provides biologics development and clinical- and commercial-scale drug substance and drug product GMP manufacturing.

**Hangzhou:** The newest facility offers integrated development, large-scale manufacturing of bulk drug substance production with four 20,000-liter bioreactors, and comprehensive drug product services.

## Quality & Compliance

As a trusted CDMO provider, Altruist is committed to delivering safe, reliable, and effective processes that meet global regulatory standards. The company maintains robust quality assurance, quality control, GMP operational systems, and IP protection & security protocols.

## Related companies

- [Celonic](/companies/celonic) (Cell-Line Development, Process Development) — [Compare](/compare/altruist-biologics/celonic)
- [Abzena](/companies/abzena) (Cell-Line Development, Process Development) — [Compare](/compare/abzena/altruist-biologics)
- [AsymBio](/companies/asymbio) (Process Development, Monoclonal Antibody (mAb) Manufacturing) — [Compare](/compare/altruist-biologics/asymbio)
- [WuXi Biologics](/companies/wuxibiologics) (Cell-Line Development, Process Development) — [Compare](/compare/altruist-biologics/wuxibiologics)
- [Creative Biolabs](/companies/creativebiolabs) (Cell-Line Development, Process Development) — [Compare](/compare/altruist-biologics/creativebiolabs)
- [KBI Biopharma, Inc.](/companies/kbibiopharma) (Cell-Line Development, Process Development) — [Compare](/compare/altruist-biologics/kbibiopharma)
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions) (Process Development, Formulation Development) — [Compare](/compare/altruist-biologics/piramalpharmasolutions)
- [AGC Biologics](/companies/agcbio) (Cell-Line Development, Process Development) — [Compare](/compare/agcbio/altruist-biologics)

_Profile last updated: 2026-08-07T00:04:03.344Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.